BRAXTON SHIDLER: Open Payments
NPI 1013660786 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$932 in 39 payments from 17 companies in 2025. Trend: 2023 $123 · 2024 $39 · 2025 $932
Food & beverage: $890Education: $43
| Company | Payments | Amount |
|---|---|---|
| Tandem Diabetes Care, Inc. | 8 | $261 |
| Medtronic, Inc. | 4 | $107 |
| Mannkind Corporation | 3 | $79 |
| Insulet Corporation | 3 | $78 |
| BETA BIONICS, INC. | 4 | $51 |
| CeQur Corporation | 1 | $46 |
| Dexcom, Inc. | 2 | $45 |
| Sequel Med Tech, LLC | 2 | $44 |
| Lilly USA, LLC | 2 | $37 |
| Corcept Therapeutics | 2 | $36 |
Products named: t:slim X2 Insulin Pump with Control-IQ, MINIMED 780G, AFREZZA, Omnipod, JARDIANCE, iLet Bionic Pancreas, CeQur Simplicity, Dexcom G6 Transmitter.
Industry payments across IN — which companies pay providers there.
